Insider · CIK 0001422345

Alrutz Michael Albert

Reports to the SEC for 2 companies · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001422345

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-04-21	CHIMERIX INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	SVP AND GENERAL COUNSEL	DDisposition to Issuer	−250K sh	—	—	0
2025-04-21	CHIMERIX INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	SVP AND GENERAL COUNSEL	DDisposition to Issuer	−135K sh	—	—	0
2025-04-21	CHIMERIX INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	SVP AND GENERAL COUNSEL	DDisposition to Issuer	−176K sh	—	—	0
2025-04-21	CHIMERIX INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	SVP AND GENERAL COUNSEL	DDisposition to Issuer	−165K sh	—	—	0
2025-04-21	CHIMERIX INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	SVP AND GENERAL COUNSEL	DDisposition to Issuer	−170K sh	—	—	0
2025-04-21	CHIMERIX INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	SVP AND GENERAL COUNSEL	DDisposition to Issuer	−200K sh	—	—	0
2025-04-21	CHIMERIX INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	SVP AND GENERAL COUNSEL	DDisposition to Issuer	−129K sh	—	—	0
2025-04-21	CHIMERIX INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	SVP AND GENERAL COUNSEL	DDisposition to Issuer	−131K sh	—	—	0
2025-04-21	CHIMERIX INCD Disposition to Issuer	SVP AND GENERAL COUNSEL	DDisposition to Issuer	−217K sh	$8.55	−$1.85M	0
2025-04-21	CHIMERIX INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	SVP AND GENERAL COUNSEL	DDisposition to Issuer	−178K sh	—	—	0
2025-04-21	CHIMERIX INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	SVP AND GENERAL COUNSEL	DDisposition to Issuer	−15K sh	—	—	0
2025-04-21	CHIMERIX INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	SVP AND GENERAL COUNSEL	DDisposition to Issuer	−45.8K sh	—	—	0
2025-02-13	CHIMERIX INCS Sale	SVP AND GENERAL COUNSEL	SSale	−1,600 sh	$4.52	−$7,226.4	213,596
2025-01-07	CHIMERIX INCA Award	SVP AND GENERAL COUNSEL	AAward	+41.7K sh	—	—	215,196
2025-01-07	CHIMERIX INCStock Option (Right to Buy)A Award	SVP AND GENERAL COUNSEL	AAward	+250K sh	—	—	250,000
2024-02-01	CHIMERIX INCA Award	SVP AND GENERAL COUNSEL	AAward	+21.9K sh	—	—	168,098
2024-02-01	CHIMERIX INCStock Option (Right to Buy)A Award	SVP AND GENERAL COUNSEL	AAward	+131K sh	—	—	131,250
2023-01-17	CHIMERIX INCStock Option (Right to Buy)A Award	SVP AND GENERAL COUNSEL	AAward	+129K sh	—	—	128,550
2023-01-17	CHIMERIX INCA Award	SVP AND GENERAL COUNSEL	AAward	+21.5K sh	—	—	142,015
2019-02-05	CHIMERIX INCA Award	SVP AND GENERAL COUNSEL	AAward	+100K sh	—	—	156,645
2010-09-22	SYNAGEVA BIOPHARMA CORPEmployee stock option (right to buy)A Award	General Counsel	AAward	+44.5K sh	—	—	44,544
2009-07-21	SYNAGEVA BIOPHARMA CORPEmployee stock option (right to buy)A Award	General Counsel	AAward	+44.5K sh	—	—	44,544
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)A Award	General Counsel	AAward	+1,300 sh	—	—	1,300
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)D Disposition to Issuer	General Counsel	DDisposition to Issuer	−1,300 sh	—	—	0
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)A Award	General Counsel	AAward	+1,300 sh	—	—	1,300
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)D Disposition to Issuer	General Counsel	DDisposition to Issuer	−1,300 sh	—	—	0
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)A Award	General Counsel	AAward	+1,300 sh	—	—	1,300
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)D Disposition to Issuer	General Counsel	DDisposition to Issuer	−905 sh	—	—	0
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)A Award	General Counsel	AAward	+905 sh	—	—	905
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)D Disposition to Issuer	General Counsel	DDisposition to Issuer	−905 sh	—	—	0
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)A Award	General Counsel	AAward	+905 sh	—	—	905
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)A Award	General Counsel	AAward	+2,813 sh	—	—	2,813
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)D Disposition to Issuer	General Counsel	DDisposition to Issuer	−3,322 sh	—	—	0
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)A Award	General Counsel	AAward	+3,322 sh	—	—	3,322
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)D Disposition to Issuer	General Counsel	DDisposition to Issuer	−3,322 sh	—	—	0
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)A Award	General Counsel	AAward	+3,322 sh	—	—	3,322
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)D Disposition to Issuer	General Counsel	DDisposition to Issuer	−3,322 sh	—	—	0
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)A Award	General Counsel	AAward	+3,322 sh	—	—	3,322
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)D Disposition to Issuer	General Counsel	DDisposition to Issuer	−3,322 sh	—	—	0
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)A Award	General Counsel	AAward	+3,322 sh	—	—	3,322
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)D Disposition to Issuer	General Counsel	DDisposition to Issuer	−44.5K sh	—	—	0
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)A Award	General Counsel	AAward	+44.5K sh	—	—	44,544
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)A Award	General Counsel	AAward	+905 sh	—	—	905
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)D Disposition to Issuer	General Counsel	DDisposition to Issuer	−905 sh	—	—	0
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)A Award	General Counsel	AAward	+905 sh	—	—	905
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)D Disposition to Issuer	General Counsel	DDisposition to Issuer	−2,813 sh	—	—	0
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)A Award	General Counsel	AAward	+2,813 sh	—	—	2,813
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)D Disposition to Issuer	General Counsel	DDisposition to Issuer	−2,813 sh	—	—	0
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)A Award	General Counsel	AAward	+2,813 sh	—	—	2,813
2009-01-27	SYNAGEVA BIOPHARMA CORPEmployee Stock Option (right to buy)D Disposition to Issuer	General Counsel	DDisposition to Issuer	−2,813 sh	—	—	0

Recent filings

Accepted (ET)
Apr 214
Alrutz Michael Albert0001415889-25-011064
SEC(opens sec.gov)
Feb 144
Alrutz Michael Albert0001415889-25-004216
SEC(opens sec.gov)
Jan 104
Alrutz Michael Albert0001415889-25-001220
SEC(opens sec.gov)
Feb 24
Alrutz Michael Albert0001415889-24-002393
SEC(opens sec.gov)
Jan 194
Alrutz Michael Albert0001209191-23-004144
SEC(opens sec.gov)
Feb 74
Alrutz Michael Albert0001209191-19-008276
SEC(opens sec.gov)

Companies

Address

2530 MERIDIAN PARKWAY 2ND FLOOR

DURHAM, NC, 27713